tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Baum, 62 are a BUY (58.49%), 40 are a HOLD (37.74%), 4 are a SELL (3.77%).
Analyst Andrew Baum, carries an average stock price target met ratio of 80.98% that have a potential upside of 32.75% achieved within 600 days. Previously, Andrew Baum worked at CITI.
Andrew Baum’s has documented 209 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 27-Jan-2026.
Analyst best performing recommendations are on ALVO (ALVOTECH).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 7/26/2023. The price target of $525 was fulfilled within 19 days with a profit of $81.61 (18.41%) receiving and performance score of 9.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2026
$325
$30.11 (10.21%)
$300
11 days ago
(21-Oct-2026)
1/3 (33.33%)
$40.2 (14.12%)
231
Buy Since 05-Feb-2020
$288
$-6.89 (-2.34%)
$288
23 days ago
(09-Oct-2026)
45/45 (100%)
$11.53 (4.17%)
407
Hold Since 07-Jan-2026
$275
$-19.89 (-6.74%)
$260
23 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Nov-2023
$290
$-4.89 (-1.66%)
$285
24 days ago
(08-Oct-2026)
32/32 (100%)
$17.58 (6.45%)
244
Buy Since 16-Oct-2020
$300
$5.11 (1.73%)
$280
24 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
